The risk of stroke following CABG: one possible strategy to reduce it?

M De Feo1, A Renzulli, F Onorati

  • 1Department of Cardiothoracic Sciences, Division of Cardiac Surgery, Second University of Naples V. Monaldi Hospital, Italy.

Insights

Routine preoperative Doppler studies (DS) and carotid endarterectomy (CEA) significantly reduced stroke incidence after coronary artery bypass grafting (CABG). This aggressive approach lowered postoperative stroke rates and mortality in patients undergoing CABG surgery.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Surgery

Background:

  • Stroke is a serious complication following coronary artery bypass grafting (CABG).
  • Current diagnostic and therapeutic strategies aim to minimize this risk.
  • The effectiveness of a proactive approach requires further evaluation.

Purpose of the Study:

  • To assess if an aggressive diagnostic and therapeutic strategy reduces stroke incidence after CABG.
  • To compare outcomes between routine and selective diagnostic testing.

Main Methods:

  • 1388 patients undergoing isolated on-pump CABG were divided into two groups: Group A (selective Doppler study) and Group B (routine Doppler study).
  • Carotid endarterectomy (CEA) was performed in selected patients.
  • Postoperative neurological symptoms were assessed via Brain CT scans.

Main Results:

  • No significant difference in hospital mortality between Group A (3.5%) and Group B (2.75%).
  • Stroke incidence was significantly lower in Group B (0.26%) compared to Group A (3.82%) (p<0.001).
  • Hospital mortality for stroke was zero in Group B versus 1.91% in Group A (p<0.001).

Conclusions:

  • Routine preoperative Doppler studies in CABG patients are effective.
  • Carotid endarterectomy under local anesthesia for critical stenosis significantly reduces postoperative stroke.
  • This aggressive diagnostic and therapeutic strategy improves patient outcomes after CABG.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...